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This study aimed to describe the distribution and characterization of fecal extended-
spectrum β-lactamase (ESBL)- and AmpC-producing Escherichia coli isolates from
healthy companion animals and cohabiting humans. A total of 968 rectal swab samples
from 340 participants, including healthy companion animals and cohabiting humans,
were collected from 130 households in South Korea from 2018 to 2019. To determine
the bacterial profiles of the participants, several experiments were performed as
follows: antimicrobial susceptibility testing, PCR and direct sequencing for ESBL/AmpC
production, PFGE, MLST, whole genome sequencing and qRT-PCR. A total of 24.9
and 21.5% of the E. coli isolates from healthy companion animals and cohabiting
humans were ESBL/AmpC producers, respectively. The blaCTX−M−14 gene was the
most prevalent ESC resistance gene in both pets (n = 25/95, 26.3%) and humans
(n = 44/126, 34.9%). The blaCMY−2 gene was also largely detected in pets (n = 19,
20.0%). Overall, intrahousehold pet-human sharing of ESBL/AmpC E. coli isolates
occurred in 4.8% of households, and the isolates were all CTX-M-14 producers. In
particular, ten CMY-2-producing E. coli isolates from seven dogs and three humans in
the different households belonged to the same pulsotype. The MIC values of cefoxitin
and the transcription level in CMY-2-producing E. coli isolates were proportional to the
blaCMY−2 copy number on the chromosome. Our results showed that the clonal spread
of fecal ESBL/AmpC-producing E. coli households’ isolates between healthy companion
animals and cohabiting humans was rare, but it could happen. In particular, E. coli
ST405 isolates carrying multiple blaCMY−2 genes on the chromosome was sporadically
spread between companion animals and humans in South Korea.
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INTRODUCTION
The close contact between companion animals and humans
may cause bacterial transmission across animals or humans
by horizontal transfer (indirect transmission) and clonal
spread (direct transmission) (Damborg et al., 2016). The
majority of studies have focused on the transmission of
human-to-companion animal with hospitalized or infected
(Bogaerts et al., 2015), but few studies have focused on the
fecal transmission of bacteria between healthy companion
animals and cohabiting humans as categorized households
(Marques et al., 2019).
Since the late 1900s, third- and fourth-generation extended-
spectrum cephalosporin (ESC)-resistant Enterobacteriaceae
have been frequently reported in both human and
veterinary fields (Schmiedel et al., 2014; Lee et al., 2018).
ESC resistance in Enterobacteriaceae is often associated
with extended-spectrum β-lactamase (ESBL) and AmpC
β-lactamase production, mainly CTX-M-type for ESBL in
Enterobacteriaceae, CMY-type for AmpC in Escherichia
coli, and DHA-type for AmpC in Klebsiella pneumoniae
(Lartigue et al., 2004; Verdet et al., 2009; Kameyama et al.,
2013). In addition, a wide diversity of carbapenemase-
producing Enterobacteriaceae has been also found worldwide
(Gauthier et al., 2018).
CMY-2 is the most prevalent AmpC β-lactamase in ESC-
resistant E. coli isolates in animals and humans worldwide
(Ewers et al., 2012; Lazarus et al., 2015). The dissemination
of the blaCMY−2 gene largely corresponds to self-transferable
IncA/C or IncI1 plasmids (Ben Sallem et al., 2014; Guo
et al., 2014), but chromosomal blaCMY−2 gene transfer through
specific ISEcp1-mediated transposition is also responsible for
the spread of the blaCMY−2 gene (Verdet et al., 2009;
Mata et al., 2012). The transcription of the blaCMY−2 gene
could be altered by a putative promoter within ISEcp1, the
correlation between ISEcp1 and CMY-2 called the spacer
sequence, and the copy number of the blaCMY−2 gene (Smet
et al., 2008; Ma et al., 2011; Kurpiel and Hanson, 2012;
Manageiro et al., 2015).
Our previous study targeted “diseased” companion animals
(Hong et al., 2019), while this study focused on “healthy”
companion animals. Namely, the significant difference
between our two studies is the study population. This
study aimed to compare the distribution and molecular
relatedness of fecal ESBL/AmpC-producing E. coli




The study population included households with healthy
companion animals and humans living together. All human
participants were informed of the main goals of this study
and were asked to sign a consent form before inclusion.
Participants who were considered “healthy” were included
if they had no bacterial infection or did not take antibiotics
in the previous month. A participant household was made
up of healthy companion animals (a dog or a cat) and one
or two cohabiting humans (a veterinarian hospital staff
and/or a staff ’s family). A total of 340 participants (101
dogs, 38 cats, 130 vet’s staff, and 71 staff ’s families) living
in 130 households belonging to 18 veterinarian hospitals
were enrolled for 2018–2019 (Supplementary Material).
All human participants were more than 16 years old,
and 70% were women. The age of companion animals
ranged from less than 1 to 16 years, and 43% were female
(data not shown).
Specimen Collection and Bacterial
Isolates
This study was carried out in accordance with the
recommendations of the ethnic guidelines of KonKuk
University College of Veterinary Medicine, South Korea.
Individual written informed consent for the use of
samples was obtained from all the vet’s staff and the
staff ’s families.
Enrolled humans collected their own rectal swab samples
and rectal swab samples from coliving companion animals
into sterile containers. The sample collection was performed
with one, two, three, four, and/or five repetitions (first in
January 2018, second in March 2018, third in September
2018, fourth in February 2019, and/or fifth in April 2019)
per participant (Supplementary Material). Specimens were
refrigerated until processing. The rectal swab samples plated
onto CHROMagar ESBL plates (CHROMagar, Paris, France)
were incubated at 36◦C for 18 h. Up to three suspected E. coli
colonies (dark pink to reddish colonies) were isolated, and a
single colony was subcultured onto a blood agar plate. The
subcultured colonies were confirmed as E. coli by matrix-assisted
laser desorption ionization-time of flight mass spectrometry
(MALDI-TOF MS) with a Vitek-MS (bioMerieux, Marcy-
Etoile, France).
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility to ampicillin, piperacillin,
ampicillin-sulbactam, cefazolin, cefoxitin, cefotaxime,
ceftazidime, cefepime, aztreonam, ertapenem, imipenem,
meropenem, amikacin, gentamicin, ciprofloxacin, and
trimethoprim-sulfamethoxazole was tested by the agar disk
diffusion method on cation-adjusted Mueller-Hinton agar
(Difco Laboratories, Detroit, MI, United States). For further
characterization, the minimum inhibitory concentrations
(MICs) of cefoxitin, cefotaxime, and ceftazidime were
determined by the broth microdilution method according
to the CLSI guidelines (CLSI, 2019), and the MICs of
colistin were assessed by the broth microdilution method
using Mueller–Hinton broth (Difco Laboratories), following
the criteria of EUCAST (2019). E. coli ATCC 25922 and
Pseudomonas aeruginosa ATCC 27853 were used for
quality control.
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Identification of Antimicrobial
Resistance Determinants and the
blaCMY−2 Promoter
Template DNA was prepared by the boiling method.
blaCTX−M−1−like, blaCTX−M−2−like, blaCTX−M−9−like, and
blaCTX−M−25−like for CTX-M-type ESBLs were amplified by
PCR and direct sequencing in cefotaxime-non-susceptible E. coli
isolates; blaDHA, blaACC, blaACT, and blaFOX for AmpCs were
amplified by PCR and direct sequencing in cefoxitin-non-
susceptible E. coli isolates; IMP-, VIM-, NDM-, KPC-, GES-, and
OXA-48-like for carbapenemases were amplified by PCR and
direct sequencing in carbapenem-non-susceptible E. coli isolates:
1138 bp region upstream of the blaCMY−2 gene within ISEcp1
and the 116 bp spacer sequence as the predicted blaCMY−2
promoter between ISEcp1 and CMY-2 for blaCMY−2 promoter as
described previously (Smet et al., 2008; Ma et al., 2011; Kurpiel
and Hanson, 2012; Manageiro et al., 2015; Hong et al., 2019). The
sequences were compared to published DNA sequences using
BLAST1.
Epidemiological Bacterial Typing
The representative E. coli isolates carrying the five predominant
ESBL/AmpC genes for epidemiological data analysis underwent
pulsed-field gel electrophoresis (PFGE) with XbaI. E. coli ATCC
25922 was included as a quality control. Multilocus sequence
typing (MLST) was performed on CMY-2-producing E. coli
isolates belonged to the same pulsotype.
Whole Genome Sequencing
The three CMY-2 producing E. coli ST405 isolates (E118, E597,
and E686) among the same pulsotype were selected. Two (E597
and E686) of the three isolates were recovered from a dog and
a human in this study, respectively. The other well-characterized
isolate (E118) was recovered from a dog in our previous study in
2017 (Hong et al., 2019). The bacterial DNA was extracted from
the three isolates using a Wizard Genomic DNA Purification kit
(Promega, Madison, WI, United States). After extraction, DNA
shearing was performed using a g-TUBE apparatus (Covaris, Inc.,
Moburn, MA, United States) and the fragments were purified by
using 0.45× of the final volume of washed Agencourt AMPure XP
magnetic beads (Beckman Coulter Inc., Brea, CA, United States)
(Hong et al., 2016). For bacterial whole genome sequencing
(WGS), single-molecule real-time sequencing was carried out
on a PacBio RSII instrument (Pacific Biosciences, Menlo Park,
CA, United States). The coding sequences, tRNA sequences, and
rRNA sequences were annotated using the NCBI Prokaryotic
Genome Annotation Pipeline2.
Quantitative Reverse Transcription PCR
The expression level of the blaCMY−2 gene in E. coli ST405 isolates
belonged to the same pulsotype was evaluated by quantitative
reverse transcription PCR (qRT-PCR) assays. The E. coli isolates
were cultured in Muller–Hinton broth at 37◦C with vigorous
1https://blast.ncbi.nlm.nih.gov/Blast.cgi
2http://www.ncbi.nlm.nih.gov/books/NBK174280
agitation until OD600 = 1.5–2, corresponding to the exponential
phase. Bacterial RNA was extracted using the RNeasy Mini Kit
(Qiagen, Hilden, Germany), and cDNA was synthesized using
the TOPscriptTM cDNA Synthesis Kit (Enzynomics, Daejeon,
South Korea). Amplification was carried out in a final volume of
20 µL containing 10 µL of premix (RbTaqTM qPCR 2X preMIX;
Enzynomics), 1 µL of each primer, 7 µL of distilled water,
and 1 µL of cDNA with a CFX96 system (Bio-Rad, Hercules,
CA, United States). Transcript measurement was carried out in
quadruplicate, and relative quantification of the blaCMY−2 gene
was calculated with the 2−1 1 CT method using 16S rRNA as
a reference. The E118 strain was measured in every batch for
comparison as a reference strain.
Data Analysis
For PFGE, the unweighted-pair group method with averaging
based on the Dice similarity coefficient and a clustering algorithm
was used to create a dendrogram. Isolates with >80% PFGE
similarity were considered as shared clones (Tenover et al., 1995).
Statistical analysis was performed using SPSS Statistics version
24.0.0 (IBM Corp., Armonk, NY, United States). The chi-square
test was used for comparisons between groups, with a p value of




A total of 968 rectal swab samples from healthy companion
animals (291 dogs and 91 cats) and their cohabiting humans (381
vet’s staff and 205 of staff ’s families) were collected from 340
participants (Supplementary Table S1).
A total of 221 ESBL/AmpC-producing E. coli isolates,
including 95 (24.9%, 95/382) healthy companion animals and
126 (21.5%, 126/586) cohabiting humans in the 130 households,
were isolated. CTX-M-14 (n = 25, 26.3%) was the most
common ESBL/AmpC β-lactamase in companion animals. CMY-
2 (n = 19, 20.0%) was the second most predominant ESBL/AmpC
β-lactamase, followed by CTX-M-55 (n = 12, 12.6%), CTX-M-15
(n = 9, 9.5%), and CTX-M-27 (n = 7, 7.4%). The blaCTX−M−14
gene (n = 44, 34.9%) was also the most common ESC-resistance
gene in cohabiting humans, followed by blaCTX−M−15 (n = 24,
19.0%), blaCTX−M−27 (n = 21, 16.7%), blaCTX−M−55 (n = 8, 6.3%),
and blaCMY−2 (n = 8, 6.3%). CTX-M-1 and CTX-M-24 were
found only in companion animals, while CTX-M-3, CTX-M-
65, and CMY-48 were detected only in humans. Several E. coli
isolates cocarrying ESBL/AmpC genes (producing ESBL+ ESBL,
ESBL+AmpC, or AmpC+AmpC) were also observed (Table 1).
Carbapenemases (IMP-, VIM-, NDM-, KPC-, GES-, and OXA-
48-like) were not detected in two imipenem-intermediate E. coli
isolates (H7h3) along with CTX-M-15 and DHA-1 recovered
from vet’s staff and staff ’s family.
The ESBL/AmpC-producing E. coli isolates in pets showed
a statistically lower susceptibility rate to ampicillin-sulbactam,
cefoxitin, ceftazidime, cefepime, aztreonam, gentamicin, and
ciprofloxacin than those in cohabiting humans but showed
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a statistically higher susceptibility rate to trimethoprim-
sulfamethoxazole than those in cohabiting humans (p value
<0.05). All isolates in companion animals and cohabiting
humans were susceptible to colistin (Figure 1).
Epidemiological Relatedness
Categorized in Households
A total of 130 non-duplicated E. coli isolates carrying the five
predominant ESBL/AmpC genes (49 of CTX-M-14, 25 of CTX-
M-15, 15 of CTX-M-27, 16 of CTX-M-55, and 25 of CMY-2) in
the 84 households were selected for subjecting to PFGE analysis.
Of the 49 E. coli isolates carrying the blaCTX−M−14 gene,
13 cases were considered as shared clones belonged to the
same pulsotype. Four cases in four households occurred as
intrahousehold pet-human sharing (H9h4, H1h11, H6h6, and
H7h16), indicating belonged to same household and same
veterinary hospital with >80% clonal similarity. Seven cases
occurred as interhousehold pet-human sharing (Figure 2A).
Of the 25 E. coli isolates carrying the blaCTX−M−15
gene, five cases had closed bacterial strain typing
(cladogram sharing >82%), and intrahousehold pet-human
sharing was absent. Two cases of them were observed:
interhousehold dog-human sharing and interhousehold dog-dog
sharing (Figure 2B).
Of the 15 CTX-M-27-producing E. coli isolates, four
cases showed shared clones without intrahousehold pet-human
sharing. One case of them was observed as interhousehold cat-
human sharing (Figure 2C).
Of the 16 E. coli isolates carrying the blaCTX−M−55
gene, two cases were considered as shared clones without
intrahousehold pet-human sharing, but each case occurred as
interhousehold dog-human sharing and interhousehold dog-dog
sharing (Figure 2D).
Of the 25 E. coli isolates carrying the blaCMY−2 gene, three
cases showed closed bacterial strain typing (cladogram sharing
>80%) without intrahousehold pet-human sharing. Two cases
of them were occurred as interhousehold dog-dog sharing. In
the remaining one case, eleven E. coli isolates (eight dogs and
three humans from different households) corresponded to ST405
by MLST analysis were included in one cluster (a) by PFGE
TABLE 1 | Genotypes of ESBL- and AmpC-producing E. coli isolates from healthy companion animals and cohabiting humans.
ESBL AmpC No. (%) of isolates
Companion animals Cohabiting humans
Dog Cat Total Vet’s staff Staff’s family Total
(n = 291) (n = 91) (n = 382) (n = 381) (n = 205) (n = 586)
CTX-M-1 2 0 2 0 0 0
CTX-M-3 0 0 0 1 1 2
CTX-M-3 + CTX-M-14 3 0 3 0 0 0
CTX-M-15 8 1 9 19 6 25
CTX-M-15 + CTX-M-14 0 0 0 2 1 3
CTX-M-15 + CTX-M-27 0 0 0 1 0 1
CTX-M-15 CMY-2 2 1 3 0 0 0
CTX-M-15 DHA-1 0 0 0 1 1 2
CTX-M-55 11 0 11 8 0 8
CTX-M-55 + CTX-M-27 0 0 0 1 2 3
CTX-M-55 + CTX-M-65 1 0 1 0 0 0
CTX-M-55 CMY-2 1 0 1 1 0 1
CTX-M-24 3 0 3 0 0 0
CTX-M-27 4 3 7 18 3 21
CTX-M-27 CMY-2 0 1 1 0 0 0
CTX-M-64 2 3 5 1 0 1
CTX-M-65 0 0 0 1 1 2
CTX-M-65 CMY-2 0 0 0 1 0 1
CTX-M-65 DHA-1 0 0 0 1 0 1
CTX-M-14 19 6 25 30 14 44
CTX-M-14 CMY-2 2 0 2 0 0 0
CTX-M-14 DHA-1 0 0 0 0 1 1
CMY-2 19 0 19 4 2 6
CMY-2 + DHA-1 2 0 2 0 0 0
CMY-48 0 0 0 1 0 1
DHA-1 1 0 1 3 0 3
Total 80 (27.5) 15 (16.5) 95 (24.9) 94 (24.7) 32 (15.6) 126 (21.5)
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FIGURE 1 | Antimicrobial susceptibilities of ESBL/AmpC-producing E. coli veterinary isolates. (A) E. coli isolates from humans (n = 125); (B) E. coli isolates from
companion animals (n = 95).
(pulsotype a1 (six dogs and two humans) with >86% clonal
similarity and pulsotype a2 (two dogs and one human) with
>90% clonal similarity), similar to the well-characterized E118
strain (E. coli ST405 canine isolate carrying the blaCMY−2 gene)
in our previous report (Hong et al., 2019; Figure 2E).
Overall, intrahousehold pet-human sharing was 4.8% (four of
the 84 households), and these shared isolates were all CTX-M-
14 producers.
Genetic Profiles of CMY-2-Producing
E. coli ST405 Isolates
The bacterial profile was further characterized, and 11 CMY-
2-producing E. coli ST405 isolates belonged to the a1 and a2
pulsotypes were divided into three groups based on their MIC
values to cefoxitin: 256 mg/L was included in group 1, 128 mg/L
was included in group 2, and 64 mg/L was included in group
3 (Table 2).
Three isolates (E118, E597, and E686) were selected from
each of the three groups, and WGS was carried out. The E597
strain (dog origin) in group 1 was composed of a 5.2 Mb
circularized chromosome carrying three copies of blaCMY−2 and
two plasmids. The first plasmid of the RepFIB type had 176 CDSs,
including only the TEM-1 gene in ca. 14.4 kb. The second repA-
type plasmid had 93 CDSs without the antimicrobial resistance
(AMR) gene in ca. 8.3 kb. The E118 strain (dog origin) in group
2 was composed of a 5.3 Mb circularized chromosome carrying
two copies of blaCMY−2 and one plasmid. The RepFIB replicon
plasmid had 175 CDSs, including TEM-1 and tet for tetracycline
resistance in ca. 14 kb. The E686 strain (human origin) in group 3
was composed of a 5.2 Mb circularized chromosome carrying one
blaCMY−2 and one plasmid. The plasmid of the RepFIB type had
191 CDSs, which included TEM-1, tet, and ant1, for streptomycin
resistance in ca. 14.4 kb (Figure 3).
The genetic environment of the first blaCMY−2 gene by
ISEcp1-mediated, truncated by IS4, in the E118 strain was
blaCMY−2-blc-yggR-tnp1-orf7-orf8-orf9-tnp2-hsdR. One inverted
repeat was located ISEcp1 left (IRL1, GGATCTAAGATGCA),
and the paired inverted repeat was ISEcp1 right (IRR1,
TGCACCTTAAATCC). The second blaCMY−2 gene sequence
by ISEcp1-mediated, adjacent to IRL2 (CCTAGATTCTACGT)
and IRR2 (ACGTGGAATTTAGG), was conversely comprised in
a different genetic organization (blaCMY−2-blc-yggR-tnp1-orf7-
orf8). This context was devoid of the last three CDSs (orf9-tnp2-
hsdR) compared to the first blaCMY−2-containing region. These
three genes were identical to a part of the Shigella flexneri serotype
2a SRL pathogenicity island, being first reported to be involved in
the transfer of antibiotic resistance (Luck et al., 2001). The paired
13 bp sequences for IRL1 and IRR1 adjacent to the configuration
(ISEcp1-blaCMY−2) in the E597 strain were identical in the
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FIGURE 2 | PFGE dendrogram of ESBL/AmpC-producing E. coli isolates by genotype. (A) CTX-M-14; (B) CTX-M-15; (C) CTX-M-27; (D) CTX-M-55; (E) CMY-2.
The red box indicates the same pulsotype (>80% similarity) as the closely related case.
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TABLE 2 | MIC and blaCMY−2 expression levels in the 11 CMY-2-producing E. coli ST405 isolates.
Isolate Household Species Coproducing ESBL/AmpC MIC Relative CMY-2 transcript
level ± SD compared to
E118 strainFOX CTX CAZ
E686 H11h2 Human No 64 16 32 0.223 ± 0.003
E911 H5h9 Human No 64 32 64 0.188 ± 0.007
E933 H6h4 Human No 64 32 64 0.307 ± 0.024
E118 (3)* Dog No 128 32 64 1
E797 H11h1 Dog No 128 32 64 1.385 ± 0.059
E891 H6h8 Dog No 128 64 256 1.594 ± 0.079
E893 H7h15 Dog CTX-M-14 128 256 64 1.935 ± 0.139
E597 H6h7 Dog No 256 32 64 5.389 ± 0.238
E777 H7h2 Dog No 256 64 128 7.374 ± 0.312
E858 H6h5 Dog No 256 32 64 4.221 ± 0.530
E941 H15h2 Dog No 256 32 64 5.324 ± 0.362
Abbreviations: Ct, cycle threshold; ST, sequence type; FOX, cefoxitin; CTX, cefotaxime; CAZ, ceftazidime; SD, standard deviation. An asterisk (*) indicates Reference 3 in
this study.
FIGURE 3 | Genetic overview of three E. coli ST405 isolates carrying chromosomally located blaCMY−2. (A) Comparison of the genetic regions surrounding the
blaCMY−2 gene. The shaded regions indicate the identical sequences sharing whatever same or converse orientation. (B) Circular genome map representation. The
outermost ring: E118 open-reading frames on both forward and reverse strands. Red and green circle represents the blast results of E597 and E686 with E118
representing the positions covered by the BLASTN alignment, respectively. G + C content, black peak; G + C positive skew, green peak; G + C negative skew,
purple peak. ¬ Region of genetic environmental structure from 2,600,492-2,613,180 bp in the E118, E597, and E686 strains identical to E. coli TN44889; ­ region
from 3,350,844-3,353,575 bp in E118 strain; ® region from 1,669,367-1,672,220 bp in E597, and ¯ region from 3,350,844-3,353,575 bp in E597 strain. (C) The
chromosome and plasmid of three CMY-2-producing E. coli isolates.
following three flanking regions in different locations on the
chromosome: (i) blaCMY−2-blc-yggR, (ii) blaCMY−2-blc-yggR-
tnp1-orf7-orf8-orf9-tnp2-hsdR, and (iii) blaCMY−2-blc. In the
E686 strain, the genetic context containing-the blaCMY−2 gene
by ISEcp1-mediated, adjacent to IRL1 and IRR1, was identified
as blaCMY−2-blc-yggR-tnp1-orf7-orf8-orf9-tnp2-hsdR, which was
identical to the genetic context of the first blaCMY−2 gene region
in the E118 strain and the second blaCMY−2 gene region in
the E597 strain. The common chromosomal genetic regions
(blaCMY−2-blc-yggR-tnp1-orf7-orf8-orf9-tnp2-hsdR) in the E118,
E597, and E686 strains were inserted in the same location, which
was from 2,600,492 to 2,613,180 bp (Figure 3).
Evaluation of blaCMY−2 Transcript Levels
The gene expression of blaCMY−2 in group 1 was substantially
elevated from 4.221- to 7.374-fold compared to the E118 strain.
Group 2 and group 3 exhibited 1.385- to 1.935-fold and 0.188-
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FIGURE 4 | Representative configuration of blaCMY−2 promoters.
(A) ISEcp1-provided putative promoter region sequence. (B) Structure of the
blaCMY−2 containing region by ISEcp1-mediated transposition. (C) sequence
analysis as predicted promoter within the 116 bp spacer between ISEcp1 and
blaCMY−2.
to 0.307-fold increases in blaCMY−2 expression, respectively,
compared to the E118 strain (Table 2).
blaCMY−2 Promoter Evaluation
We evaluated two sequences previously presumed to be involved
in high levels of ESBL/AmpC gene expression (Smet et al., 2008;
Ma et al., 2011; Kurpiel and Hanson, 2012; Manageiro et al.,
2015): ISEcp1-provided promoter region sequence and a spacer
sequence in front of blaCMY−2 (Figure 4). For the examined
sequences, all 11 CMY-2-producing E. coli ST405 isolates shared
100% identity for above two putative promoter sequences related
to high levels of ESBL/AmpC gene expression.
DISCUSSION
In our previous study, CMY-2 was the most prevalent
ESBL/AmpC enzyme in diseased companion animals, accounting
for 26.4% of the ESBL/AmpC enzymes, and CTX-M-14 and
CTX-M-55 were the second most abundant enzymes. In addition,
NDM-5 was detected in four E. coli isolates from four dogs along
with blaCTX−M−15 and blaCMY−2 (Hong et al., 2019). However, in
this study, CTX-M-14 was equally highest in healthy companion
animals and cohabiting humans, and no carbapenemase genes
were detected. Interestingly, the rate of ESBL/AmpC-producing
E. coli isolates recovered from healthy companion animals and
cohabiting humans was high, observing in more than 20% of
the total rectal swab samples. The fact that companion animals
could play an important role as a reservoir of AMR bacteria
to humans has been reported previously (Day, 2011). In this
regard, colonized feces of healthy companion animals can be
considered a carrier for potentially transferring ESBL and/or
AmpC β-lactamase for ESC resistance to humans.
To analyze clonal relatedness among predominant
ESBL/AmpC-producing E. coli isolates from healthy companion
animals and cohabiting humans, several closely related clonal
lineages belonged to the same pulsotype were observed. Of
them, intrahousehold pet-human sharing of AMR bacteria was
observed in four cases (4.3%) of the 130 households. Therefore,
this result showed that AMR households’ isolate could be shared
between companion animals and humans, which was considered
intrahousehold pet-human sharing, while largely occurred by
interhousehold pet-human sharing with unknown routes of
transmission of E. coli isolates colonization.
The clonal relationship of eleven CMY-2-producing E. coli
ST405 isolates belonged to the a1 and a2 pulsotypes showed
cladograms sharing >82%, but the isolates belonged to different
households. In other words, these cases were considered
interhousehold pet-human sharing. Chromosomal concordance
between three CMY-2-producing E. coli ST405 isolates (E118,
E597, and E686) was high (>98%), and prophage sequences
were also identical by WGS analysis. Although they shared
one identical genetic environment (blaCMY−2-blc-yggR-tnp1-
orf7-orf8-orf9-tnp2-hsdR), which was identical to the genetic
context of the clinical isolate E. coli TN44889 in 2004 (Verdet
et al., 2009), the E118, E597, and E686 strains had different
blaCMY−2 copy numbers and different blaCMY−2-containing
regions. In this regard, our findings shed doubt whether the three
E. coli ST405 isolates were considered as clonal spread based
on PFGE analysis, or sporadic spread based on WGS analysis.
This is important because if WGS methodology is used, the
clonal relatedness of the strains could be different compared
to methodology based on PFGE. This doubt demonstrates
that epidemiological questions regarding the mechanism for
dissemination of resistance determinants should be clarified to
better understand the epidemiology of bacteria (de Been et al.,
2014). In this study, intrahousehold pet-human sharing cases
are likely to be considered as cases by clonal spread, while
interhousehold cases seem to be sporadic spread.
We initially prospected the blaCMY−2 gene as the often
observed plasmid-mediated AmpC β-lactamase (Verdet et al.,
2009; Kameyama et al., 2013), but the locations of three blaCMY−2
genes on the chromosome were confirmed by WGS analysis.
In the remaining E. coli ST405 isolates, the blaCMY−2 gene was
suspected to be a chromosomal gene. This is because there are
two identical 13 bp sequences (paired IRL1 and IRR1) adjacent
to ISEcp1 and similar antimicrobial susceptibility phenotypes in
11 CMY-2-producing E. coli ST405 isolates. This result suggested
that integration of the blaCMY−2-containing environment into
the chromosome of certain ST405 clone appears to be involved
in the dissemination of cefoxitin-resistant E. coli in South Korea.
CTX-M-type ESBL, especially CTX-M-15, is commonly more
dominant than CMY-type AmpC β-lactamases in humans (Lee
et al., 2018), but CMY-2-producing E. coli isolates have been
frequently detected as much as CTX-M-type in veterinary
medicine worldwide (Pietsch et al., 2018; Donà et al., 2019;
Hong et al., 2019). Interestingly, cefoxitin is often used in the
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veterinary field for treating gram-positive and anaerobic bacterial
infections (Brook et al., 2013; Lappin et al., 2017). It is likely that
veterinary gram-negative isolates can also become resistant by
multiple transpositions of the blaCMY−2 gene owing to cefoxitin
selective pressure and then may accelerate the dissemination of
cefoxitin-resistant E. coli.
For the three classified groups in 11 CMY-2-producing E. coli
ST405 isolates, regarding the relationship between the MIC
values of cefoxitin and the transcription level, the MIC values
of cefoxitin were proportional to the blaCMY−2 copy number,
varying from one to three copies. However, no mutations were
observed in the 1138 bp upstream sequence of the blaCMY−2 gene
and the 116 bp spacer sequence (Smet et al., 2008; Ma et al.,
2011; Kurpiel and Hanson, 2012; Manageiro et al., 2015). This
finding indicated that the higher level of blaCMY−2 expression
correlated with multiple copy numbers of the blaCMY−2 gene is
a key factor rather than the blaCMY−2 promoter mutation, but
it could not be excluded a limitation that the total number of
CMY-2-producing E. coli ST405 isolates analyzed in this study
was only eleven.
Unfortunately, we initially tried to isolate samples up to five
times per participants during the collection procedure to enhance
the accuracy of the study, but the number of sampling actually
varied from one to five due to individual circumstances of
the participants.
Conclusion
This study presented the intrahousehold pet-human sharing
of fecal ESBL/AmpC-producing E. coli isolates in healthy
companion animals and cohabiting humans, indicating that
the colonized feces of healthy companion animals could be
a reservoir for spreading AMR bacteria to humans. Notably,
E. coli ST405 isolates carrying multiple blaCMY−2 genes on the
chromosome sporadically spread between companion animals
and humans in South Korea. In addition, the gene copy number
on the chromosome seems to be the most important factor
affecting the transcription level of the AMR gene.
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